Ozogamicin

Ozogamicin is a cytotoxic drug-linker used in the construction of antibody-drug conjugates (ADCs) like gemtuzumab ozogamicin. It is a key component for research into targeted cancer therapies, enabling in vitro and in vivo studies of ADC mechanisms and efficacy against specific malignancies.

Product Specifications

CAS Number

400046-53-9

Smiles

CCN ([C@H]1CO[C@H] (C[C@@H]1OC) O[C@@H]2[C@H] ([C@@H] ([C@H] (O[C@H]2O[C@H]3C#C/C=C\C#C[C@@]\4 (CC (=O) C (=C3/C4=C\CSSC (C) (C) CC (=O) N/N=C (\C) /C5=CC=C (C=C5) OCCCC (=O) N) NC (=O) OC) O) C) NO[C@H]6C[C@@H] ([C@@H] ([C@H] (O6) C) SC (=O) C7=C (C (=C (C (=C7OC) OC) O[C@H]8[C@@H] ([C@@H] ([C@H] ([C@@H] (O8) C) O) OC) O) I) C) O) O) C (=O) C